Can Fas (CD95) modulation offer therapeutic potential?
Given its role in apoptosis, modulating Fas signaling presents potential therapeutic opportunities. In cases where excessive apoptosis contributes to disease, such as in neurodegenerative disorders or myocardial infarction, inhibiting Fas activity could mitigate cell loss. Conversely, enhancing Fas signaling might be beneficial in cancer treatment, where inducing apoptosis in tumor cells is desired. However, such strategies require careful balance to avoid adverse effects, highlighting the complexity of targeting Fas in therapeutic contexts.
